Researchers Detect Variants Tied to Second Cancer after Hodgkin's Treatment in Childhood | GenomeWeb

By Andrea Anderson

NEW YORK (GenomeWeb News) – Two genetic variants are associated with increased risk of second cancers called "radiation therapy-induced second malignant neoplasms" (SMNs) in individuals treated for Hodgkin's lymphoma in childhood, researchers reported in Nature Medicine online yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.